Wall Street Analyst Initiated Baxter International Inc. [BAX]. What else is Wall St. saying

Related

Share

Baxter International Inc. [NYSE: BAX] gained 0.95% on the last trading session, reaching $74.56 price per share at the time. The company report on August 11, 2021 that Miromatrix Announces Key Strategic Investors to Advance the Development of Bioengineered Livers and Kidneys.

The biotechnology company working to eliminate the organ transplant waitlist outlines expansion of its clinical work, supported by IPO funds and Series C round, led by Baxter, CareDx, and DaVita.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save patients’ lives and improve quality of life around the world, announced strategic investors involved in its Series C financing, which was followed by its June 24th IPO.

Baxter International Inc. represents 503.00 million in outstanding shares, while the company has a total market value of $36.92 billion with the latest information. BAX stock price has been found in the range of $73.55 to $74.76.

If compared to the average trading volume of 2.88M shares, BAX reached a trading volume of 2958637 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Here is what top equities market gurus are saying about Baxter International Inc. [BAX]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for BAX shares is $94.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on BAX stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Barclays have made an estimate for Baxter International Inc. shares, keeping their opinion on the stock as Equal Weight, with their previous recommendation back on May 25, 2021. While these analysts kept the previous recommendation, Piper Sandler raised their target price from $100 to $80. The new note on the price target was released on January 29, 2021, representing the official price target for Baxter International Inc. stock. Previously, the target price had yet another drop from $95 to $85, while UBS kept a Neutral rating on BAX stock. On December 15, 2020, analysts decreased their price target for BAX shares from 96 to 85.

The Average True Range (ATR) for Baxter International Inc. is set at 1.26, with the Price to Sales ratio for BAX stock in the period of the last 12 months amounting to 3.03. The Price to Book ratio for the last quarter was 4.41, with the Price to Cash per share for the same quarter was set at 6.33. Price to Free Cash Flow for BAX in the course of the last twelve months was 43.19 with Quick ratio for the last quarter at 1.80.

Trading performance analysis for BAX stock

Baxter International Inc. [BAX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.36. With this latest performance, BAX shares dropped by -8.02% in over the last four-week period, additionally sinking by -5.30% over the last 6 months – not to mention a drop of -11.91% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for BAX stock in for the last two-week period is set at 31.42, with the RSI for the last a single of trading hit 31.25, and the three-weeks RSI is set at 33.25 for Baxter International Inc. [BAX]. The present Moving Average for the last 50 days of trading for this stock 79.94, while it was recorded at 74.05 for the last single week of trading, and 80.56 for the last 200 days.

Baxter International Inc. [BAX]: A deeper dive into fundamental analysis

Operating Margin for any stock indicates how profitable investing would be, and Baxter International Inc. [BAX] shares currently have an operating margin of +15.57 and a Gross Margin at +40.06. Baxter International Inc.’s Net Margin is presently recorded at +9.44.

Return on Total Capital for BAX is now 12.37, given the latest momentum, and Return on Invested Capital for the company is 7.82. Return on Equity for this stock inclined to 13.30, with Return on Assets sitting at 5.77. When it comes to the capital structure of this company, Baxter International Inc. [BAX] has a Total Debt to Total Equity ratio set at 78.31. Additionally, BAX Total Debt to Total Capital is recorded at 43.92, with Total Debt to Total Assets ending up at 33.99. Long-Term Debt to Equity for the company is recorded at 72.36, with the Long-Term Debt to Total Capital now at 40.58.

Reflecting on the efficiency of the workforce at the company, Baxter International Inc. [BAX] managed to generate an average of $22,040 per employee. Receivables Turnover for the company is 5.88 with a Total Asset Turnover recorded at a value of 0.61.Baxter International Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.80 and a Current Ratio set at 2.40.

Baxter International Inc. [BAX]: An earnings per share (EPS) analysis

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for BAX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Baxter International Inc. go to 11.65%.

An analysis of insider ownership at Baxter International Inc. [BAX]

There are presently around $32,286 million, or 89.10% of BAX stock, in the hands of institutional investors. The top three institutional holders of BAX stocks are: WELLINGTON MANAGEMENT GROUP LLP with ownership of 51,106,228, which is approximately 23.547% of the company’s market cap and around 0.20% of the total institutional ownership; VANGUARD GROUP INC, holding 38,942,060 shares of the stock with an approximate value of $2.9 billion in BAX stocks shares; and BLACKROCK INC., currently with $2.81 billion in BAX stock with ownership of nearly -6.266% of the company’s market capitalization.

>> 7 Top Picks for the Post-Pandemic Economy <<

Positions in Baxter International Inc. stocks held by institutional investors increased at the end of July and at the time of the July reporting period, where 446 institutional holders increased their position in Baxter International Inc. [NYSE:BAX] by around 32,820,427 shares. Additionally, 487 investors decreased positions by around 23,008,519 shares, while 244 investors held positions by with 377,196,158 shares. The mentioned changes placed institutional holdings at 433,025,104 shares, according to the latest SEC report filing. BAX stock had 88 new institutional investments in for a total of 1,759,022 shares, while 75 institutional investors sold positions of 1,119,962 shares during the same period.

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam